Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Antimicrobial agents and chemotherapy · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
William S LawrenceDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-0167-8169
Jennifer E PeelDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Richard A SlaydenDepartment of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, Colorado, USA.
Johnny W PetersonDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Wallace B BazeDepartment of Comparative Medicine and Research, University of Texas MD Anderson, Bastrop, Texas, USA.
Martha E HenselDepartment of Comparative Medicine and Research, University of Texas MD Anderson, Bastrop, Texas, USA.ORCID 0000-0001-8520-0279
Elbert B WhortonDepartment of Epidemiology, University of Texas Medical Branch, Galveston, Texas, USA.
David W C BeasleyDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-3252-690X
Jason E CummingsDepartment of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, Colorado, USA.
Ines Macias-PerezProduct Development Division, Cumberland Pharmaceuticals, Nashville, Tennessee, USA.
Funding
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) HHSN272201700040I/75N93019F00271NIAID NIH HHS HHSN272201700040I
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.